MerckToday's Merck is a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships.

Merck RSS Channel

Display # 
Title Published Date
Merck Establishes Joint Venture with Supera Farma 15 February 2012
Merck Publishes 2010 Global Corporate Responsibility Report 03 October 2011
Merck Statement on GARDASIL® 16 September 2011
Merck and Serum Institute Announce Collaboration 12 August 2011
ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) Awarded Prix Galien USA 2010 Top Honor 01 October 2010
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication SAPHRIS® 09 September 2010
Merck Provides New Funding to Fight HIV/AIDS in Botswana 25 August 2010
Single Treatment with ELONVA® Produced Live Birth Rates Comparable to Daily rFSH Injections 30 June 2010
New SIMPONI (Golimumab) Data Shows Sustained Efficacy in the Treatment of Rheumatoid Arthritis 23 June 2010
Merck Announces Launch of Pioneering Collaborative Cancer Trials Network 04 June 2010
Results of the clinical study CALYPSO Published in The Journal of Clinical Oncology 26 May 2010
Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy 12 May 2010
Merck Announces First-Quarter 2010 Financial Results 05 May 2010
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA® 23 November 2009
New Merck Begins Operations 05 November 2009
Merck and Schering-Plough to Merge 10 March 2009
Two Merck Medicines Recommended for Approval in the European Union 25 April 2008
Merck & Co., Inc. Announces Completion of NovaCardia, Inc. Acquisition 13 September 2007
Merck Announces Fourth Quarter 2007 Dividend 27 July 2007
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL® 20 June 2007

Digest World Pharma Newsletter

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]